Cantourage Group SE (ETR:HIGH)
Germany
· Delayed Price · Currency is EUR 5.84
+0.16 (2.82%)
At close: Apr 29, 2026
Cantourage Group SE Company Description
Cantourage Group SE operates as a medical cannabis company in Europe and internationally.
The company offers cannabis flowers, extracts, dronabinol, tetrahydrocannabinol, and cannabidiol products.
It exports its products. The company distributes its products through pharmacies, wholesalers, and partners.
Cantourage Group SE was founded in 2019 and is headquartered in Berlin, Germany.
Cantourage Group SE
| Country | Germany |
| Founded | 2019 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 7 |
| CEO | Philip Schetter |
Contact Details
Address: Feurigstr. 54 Berlin, 10827 Germany | |
| Phone | 49 30 4701 350 51 |
| Website | cantourage.com |
Stock Details
| Ticker Symbol | HIGH |
| Exchange | Deutsche Börse Xetra |
| Fiscal Year | January - December |
| Reporting Currency | EUR |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Philip Schetter | Chief Executive Officer and Chairman of Management Board |
| Monique Jaqqam | Chief Financial Officer and Member of Exceutive Board |
| Bernhard Retzer | Vice President Sourcing and Sales and Member of Executive Board |
| Constanze Pelzer | Vice President Quality and Regulatory Affairs and Member of Executive Board |
| Manuel Taverne | Head of Investor Relations |